Revised SPC: Ninlaro (ixazomib citrate) hard capsules

SPC warns of cases, some fatal, of thrombotic microangiopathy (TMA), including thrombotic thrombocytopenic purpura. Signs and symptoms of TMA should be monitored for, and treatment stopped if TMA is suspected.

Source:

electronic Medicines compendium